Ajay Major: Bridging Radiotherapy and Systemic Therapy – Impact on Outcomes Before Axi-Cel

Ajay Major, Assistant Professor of Medicine at the University of Colorado School of Medicine, shared a post on X:

“Bridging RT v systemic tx retrospective before axi-cel ASH24:
– 98 pts, 35 RT bridging alone
– CR 85% RT, 71% chemo (not significant)
– 1-yr PFS 75% RT, 49% chemo (significant)
– MV model PFS: improved PFS (HR 0.41) with RT alone
Time for a randomized trial.”

More posts featuring Ajay Major.

Ajay Major is an Assistant Professor of Medicine at the University of Colorado School of Medicine, specializing in lymphoma and CLL/SLL. He is the Founder and President of Pager Publications, as well as the Founder and Editor-in-Chief of in-House. Additionally, he serves as a Reviewer for the Bellevue Literary Review.